9715 KEY WEST AVENUE, ROCKVILLE, MD
Milestone Payment Achieved Under CVR Agreement - $33.4 Million Due
Announces First Quarter 2026 Financial Results
Annual Report to Security Holders
Supernus Pharmaceuticals Enters Asset Purchase Agreement with Navitor
Announces Record Fourth Quarter and Full Year 2025 Financial Results
Executive Compensation Modifications for Jack A. Khattar Approved
To Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
News, Material Contracts
Q1
FY 2025
Q3
Q2
FY 2023
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party
S-8 POS